SAC.DE - SANOCHEMIA Pharmazeutika AG

XETRA - XETRA Delayed Price. Currency in EUR

SANOCHEMIA Pharmazeutika AG

Boltzmanngasse 11
Vienna 1090
43 1 319 14 56 324

IndustryDrug Manufacturers - Major
Full Time Employees

Key Executives

Dr. Werner Josef Frantsits Ph.D.Founder and Member of the Supervisory BoardN/AN/AN/A
Dr. Stefan WelzigCFO, Chief Technical Officer, Head of Production, Technology & Fin. and Member of the Mgmt BoardN/AN/AN/A
Dr. Klaus GerdesCOO, Head of Mktg & Sales, R&D, IR, New Bus. Devel. and Member of the Mgmt BoardN/AN/AN/A
Dr. Christina AbrahamsbergCSO, Head of R&D & Veterinary Medicine and Member of the Management BoardN/AN/AN/A
Amounts are as of December 31, 2005 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


SANOCHEMIA Pharmazeutika AG, a specialty pharmaceuticals company, develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology. It offers active pharmaceutical ingredients; sterile and semi-sterile liquid, and semi-liquid presentations, such as antibiotics and hormones; clinical diagnostics; and veterinary pharmaceuticals, as well as radiological products, including a range of X-ray imaging agents and the MRT imaging agents. The company's products include Tolperisone, a muscle relaxant; galantamine that is used in an Alzheimer's disease; and PVP hypericine, a patented photoactive substance for use in the diagnosis of urinary bladder cancer. It also researches and develops in therapeutic areas, such as painful muscle spasms/spasticity, and bladder cancer diagnostic; and offers contract manufacturing services. The company was founded in 1990 and is headquartered in Vienna, Austria.

Corporate Governance

SANOCHEMIA Pharmazeutika AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.